HED-Start: Evaluating a Positive Skills Intervention for Patients New on Haemodialysis
Primary Purpose
End Stage Renal Disease on Dialysis, End Stage Renal Failure on Dialysis, End Stage Renal Disease
Status
Unknown status
Phase
Not Applicable
Locations
Singapore
Study Type
Interventional
Intervention
HED-Start
Sponsored by
About this trial
This is an interventional supportive care trial for End Stage Renal Disease on Dialysis
Eligibility Criteria
Inclusion Criteria:
- Patients diagnosed with end-stage kidney disease (ESKD) and established on hemodialysis with the National Kidney Foundation Singapore (NKF) for fewer than 90 days
- At least 21 years old
- Proficient in spoken and written English or Mandarin
Exclusion Criteria:
- Unwilling or unable to give informed consent or refuse to be randomized
- Have cognitive impairments or psychiatric conditions that preclude consent
- Are currently involved in other intervention trials
- Are failing on dialysis and approaching end of life (supportive/palliative care pathway)
Sites / Locations
- National Kidney Foundation SingaporeRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
HED-Start Intervention arm
Standard care arm
Arm Description
Participants assigned to the intervention arm will undergo 4 sessions of the HED-Start program. Each session is 2 hours long and will be conducted fortnightly.
Participants assigned to the standard care arm will proceed with routine standard care.
Outcomes
Primary Outcome Measures
Change in Anxiety and Depression (HADS) scores from baseline
Hospital Anxiety and Depression Scale (HADS). The HADS comprises two subscales (anxiety; depression) and can be totaled to produce an overall scale score. Scores range from 0 to 21 for each subscale, and from 0 to 42 for the overall score. Higher scores are indicative of worse anxiety and depression symptoms.
Secondary Outcome Measures
Change in Quality of life (WHOQOL-BREF) scores from baseline
World Health Organization Quality of Life instrument (WHOQOL-BREF). Two global items (overall quality of life; general health) and two subscales (psychological health; social relationships) from the WHOQOL-BREF are used. Global scores range from 1 to 5, while subscale scores range from 4 to 20. Higher scores indicate better quality of life.
Change in kidney disease-related quality of life (KDQOL-SF) scores from baseline
Kidney Disease Quality of Life instrument (KDQOL-SF). The Burden of Kidney Disease subscale from the KDQOL-SF will be administered. Scores range from 0 to 100, with a higher score reflecting better quality of life.
Change in Illness Perception scores from baseline
Brief Illness Perception Questionnaire (BIPQ). The BIPQ consists of 8 subscales (i.e., Consequence, Timeline, Identity, Personal Control, Treatment Control, Concern, Coherence, and Emotional Representation). Subscale scores range from 0 to 10, with higher scores reflective of more negative illness perceptions.
Change in Positive and Negative Affect scores from baseline
Scale of Positive and Negative Experience (SPANE). The SPANE comprises 6 items assessing positive affect and 6 items assessing negative affect. Subscale scores range from 6 to 30. Higher scores in the Positive and Negative affect subscale indicate greater positive and negative affect respectively.
Change in Self-Efficacy for Managing Chronic Disease 6-item Scale scores from baseline
Self-Efficacy for Managing Chronic Disease 6-item Scale. The overall scale score ranges from 1 to 10. Higher scores reflect greater self-efficacy.
Change in Benefit finding in hemodialysis (BFS) scores from baseline
Benefit Finding Scale (BFS). Two subscales (personal growth; acceptance) and an overall score can be computed. All scores range from 1 to 4, with a higher score reflecting a greater extent of benefit finding.
Change in Resilience scores from baseline
2-item Connor-Davidson Resilience Scale (CD-RISC-2). The CD-RISC-2 score ranges from 0 to 8. Higher scores indicate greater resilience.
Change in Health Education Impact Questionnaire scores from baseline
Health Education Impact Questionnaire (heiQ). Six subscales from the heiQ (Positive and Active Engagement in Life, Skill and Technique Acquisition, Constructive Attitudes and Approaches, Self-Monitoring and Insight, Health Services Navigation, and Social Integration and Support) will be used to assess other self-management skills. Scores range from 1 to 4. Higher scores indicate greater proficiency with the relevant skill domain.
Full Information
NCT ID
NCT04774770
First Posted
February 23, 2021
Last Updated
May 7, 2021
Sponsor
Nanyang Technological University
Collaborators
National Kidney Foundation, Singapore
1. Study Identification
Unique Protocol Identification Number
NCT04774770
Brief Title
HED-Start: Evaluating a Positive Skills Intervention for Patients New on Haemodialysis
Official Title
HED-Start: A Randomised Controlled Trial to Evaluate a Positive Skills Intervention for Patients New on Haemodialysis
Study Type
Interventional
2. Study Status
Record Verification Date
May 2021
Overall Recruitment Status
Unknown status
Study Start Date
May 2021 (Anticipated)
Primary Completion Date
September 22, 2022 (Anticipated)
Study Completion Date
September 22, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Nanyang Technological University
Collaborators
National Kidney Foundation, Singapore
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Hemodialysis patients often experience barriers and misperceptions that hinder adjustment to life on dialysis. This study seeks to explore a group-based intervention (titled HED-Start) developed to improve self-care and emotional wellbeing among incident hemodialysis patients.
Detailed Description
There are potentially modifiable psychosocial barriers and misperceptions about life on dialysis that hinder adjustment outcomes. It is hypothesized that these may include: poor understanding on what is needed or 'how to implement treatment principles', misperceptions related to disease and treatment, catastrophizing beliefs about impact of dialysis and low level of confidence on ability to manage treatment regime and renegotiate life roles as a "dialysis patient".
This study seeks to explore the feasibility and acceptability of implementing a two-arm parallel randomized controlled trial of a group-based intervention (titled HED-Start). HED-Start is specifically developed to reduce psychological distress and support self-care and self-management outcomes in incident hemodialysis patients.
Drawing on self-management and motivational interviewing principles paradigm, the HED-Start program aims to facilitate acquisition of skills and knowledge to support and improve self-care and emotional adjustment outcomes.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
End Stage Renal Disease on Dialysis, End Stage Renal Failure on Dialysis, End Stage Renal Disease, End Stage Kidney Disease
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care ProviderOutcomes Assessor
Masking Description
Care providers (dialysis nurses) and outcomes assessors (research staff conducting the baseline and follow-up questionnaires) will be blinded to participant allocation.
Allocation
Randomized
Enrollment
148 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
HED-Start Intervention arm
Arm Type
Experimental
Arm Description
Participants assigned to the intervention arm will undergo 4 sessions of the HED-Start program. Each session is 2 hours long and will be conducted fortnightly.
Arm Title
Standard care arm
Arm Type
No Intervention
Arm Description
Participants assigned to the standard care arm will proceed with routine standard care.
Intervention Type
Behavioral
Intervention Name(s)
HED-Start
Intervention Description
The HED-Start Program is a cognitive-behavioral intervention based on self-management and motivational interviewing principles.
Primary Outcome Measure Information:
Title
Change in Anxiety and Depression (HADS) scores from baseline
Description
Hospital Anxiety and Depression Scale (HADS). The HADS comprises two subscales (anxiety; depression) and can be totaled to produce an overall scale score. Scores range from 0 to 21 for each subscale, and from 0 to 42 for the overall score. Higher scores are indicative of worse anxiety and depression symptoms.
Time Frame
Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization
Secondary Outcome Measure Information:
Title
Change in Quality of life (WHOQOL-BREF) scores from baseline
Description
World Health Organization Quality of Life instrument (WHOQOL-BREF). Two global items (overall quality of life; general health) and two subscales (psychological health; social relationships) from the WHOQOL-BREF are used. Global scores range from 1 to 5, while subscale scores range from 4 to 20. Higher scores indicate better quality of life.
Time Frame
Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization
Title
Change in kidney disease-related quality of life (KDQOL-SF) scores from baseline
Description
Kidney Disease Quality of Life instrument (KDQOL-SF). The Burden of Kidney Disease subscale from the KDQOL-SF will be administered. Scores range from 0 to 100, with a higher score reflecting better quality of life.
Time Frame
Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization
Title
Change in Illness Perception scores from baseline
Description
Brief Illness Perception Questionnaire (BIPQ). The BIPQ consists of 8 subscales (i.e., Consequence, Timeline, Identity, Personal Control, Treatment Control, Concern, Coherence, and Emotional Representation). Subscale scores range from 0 to 10, with higher scores reflective of more negative illness perceptions.
Time Frame
Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization
Title
Change in Positive and Negative Affect scores from baseline
Description
Scale of Positive and Negative Experience (SPANE). The SPANE comprises 6 items assessing positive affect and 6 items assessing negative affect. Subscale scores range from 6 to 30. Higher scores in the Positive and Negative affect subscale indicate greater positive and negative affect respectively.
Time Frame
Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization
Title
Change in Self-Efficacy for Managing Chronic Disease 6-item Scale scores from baseline
Description
Self-Efficacy for Managing Chronic Disease 6-item Scale. The overall scale score ranges from 1 to 10. Higher scores reflect greater self-efficacy.
Time Frame
Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization
Title
Change in Benefit finding in hemodialysis (BFS) scores from baseline
Description
Benefit Finding Scale (BFS). Two subscales (personal growth; acceptance) and an overall score can be computed. All scores range from 1 to 4, with a higher score reflecting a greater extent of benefit finding.
Time Frame
Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization
Title
Change in Resilience scores from baseline
Description
2-item Connor-Davidson Resilience Scale (CD-RISC-2). The CD-RISC-2 score ranges from 0 to 8. Higher scores indicate greater resilience.
Time Frame
Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization
Title
Change in Health Education Impact Questionnaire scores from baseline
Description
Health Education Impact Questionnaire (heiQ). Six subscales from the heiQ (Positive and Active Engagement in Life, Skill and Technique Acquisition, Constructive Attitudes and Approaches, Self-Monitoring and Insight, Health Services Navigation, and Social Integration and Support) will be used to assess other self-management skills. Scores range from 1 to 4. Higher scores indicate greater proficiency with the relevant skill domain.
Time Frame
Participants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients diagnosed with end-stage kidney disease (ESKD) and established on hemodialysis with the National Kidney Foundation Singapore (NKF) for fewer than 90 days
At least 21 years old
Proficient in spoken and written English or Mandarin
Exclusion Criteria:
Unwilling or unable to give informed consent or refuse to be randomized
Have cognitive impairments or psychiatric conditions that preclude consent
Are currently involved in other intervention trials
Are failing on dialysis and approaching end of life (supportive/palliative care pathway)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Konstadina Griva, PhD
Phone
+6569047348
Email
konstadina.griva@ntu.edu.sg
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Konstadina Griva, PhD
Organizational Affiliation
Nanyang Technological University
Official's Role
Principal Investigator
Facility Information:
Facility Name
National Kidney Foundation Singapore
City
Singapore
Country
Singapore
Individual Site Status
Recruiting
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
All deidentified IPD that underlie results in a publication will be available upon reasonable request.
Citations:
PubMed Identifier
34548369
Citation
Griva K, Chia JMX, Goh ZZS, Wong YP, Loei J, Thach TQ, Chua WB, Khan BA. Effectiveness of a brief positive skills intervention to improve psychological adjustment in patients with end-stage kidney disease newly initiated on haemodialysis: protocol for a randomised controlled trial (HED-Start). BMJ Open. 2021 Sep 21;11(9):e053588. doi: 10.1136/bmjopen-2021-053588.
Results Reference
derived
Learn more about this trial
HED-Start: Evaluating a Positive Skills Intervention for Patients New on Haemodialysis
We'll reach out to this number within 24 hrs